GSA Capital Partners’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

GSA Capital Partners’s Portfolio DRTX Stock Details DRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-11,400	Closed	-$145K	–	2091
2014 Q3	$145K	Buy	+11,400	New	+$170K	0.01%	1585

GSA Capital Partners's DRTX Position: Q4 2014 in Review

GSA Capital Partners sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 11,400 shares — an estimated $145K sold.

GSA Capital Partners first reported a position in DRTX in Q3 2014 and held it in 1 quarter. The position peaked at $145K in Q3 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

GSA Capital Partners reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
GSA Capital Partners sold 11,400 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $145K.
GSA Capital Partners first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q3 2014 and held it in 1 quarter.
GSA Capital Partners's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $145K in Q3 2014.
0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on GSA Capital Partners's 13F filing for Q4 2014, filed 5 Feb 2015.